- 501 Orchard Road, #04-08 Wheelock Place, Singapore 238880
- (65) 6235 4429
- hello@vidaskinclinic.com
- (65) 9830 0597
The rise of GLP-1 receptor agonist medications has led to a sharp increase in significant, often rapid weight loss. A common side effect that patients and clinicians have noted is facial volume loss, where the face appears more hollow, aged, or deflated than the rest of the body’s weight change would suggest.
This isn’t a separate medical condition so much as an accelerated, more pronounced version of a process that already happens with age and weight loss generally. Understanding the mechanism helps explain why targeted facial treatment, alongside weight loss, is increasingly considered part of a complete care plan.
GLP-1 receptor agonists work by mimicking a gut hormone that regulates appetite and blood sugar, leading to reduced food intake and, for many patients, substantial weight loss over a relatively short period compared with more gradual weight loss approaches. The face, like the rest of the body, contains fat, and it is not exempt from this reduction.
The face has comparatively little fat to begin with relative to other areas of the body, so even a modest reduction in facial fat can be proportionally more noticeable than the same percentage loss elsewhere. Because facial fat also plays a structural role in supporting the overlying skin, its loss can become visible relatively early in a weight-loss journey.
Research on GLP-1-induced facial change indicates that midfacial volume loss occurs mainly in the superficial fat compartments, the layer of fat closest to the skin’s surface, contributing to a flatter contour and more visible transitions between facial areas.
The changes are not limited to fat alone. The same body of research describes a combination of superficial fat compartment deflation, loss of deeper structural support, and increased skin laxity, along with some degree of underlying skeletal remodelling. This multi-layered pattern is part of why facial changes after significant weight loss can look different from fat loss in other body areas.
Age-related facial volume loss tends to occur gradually over many years, giving the skin and surrounding tissue time to adapt incrementally. GLP-1-related volume loss can occur over a much shorter timeframe, sometimes months, which may not allow the same degree of tissue adaptation and can make the resulting hollowing or laxity appear more sudden and pronounced relative to a patient’s age.
Because skin laxity and reduced tissue quality often accompany the volume loss, treatments that stimulate the skin’s own collagen production, such as bio-remodelling hyaluronic skin boosters, are commonly recommended early, to support the skin’s structural resilience before or alongside volume restoration.
Hyaluronic acid dermal filler is used to selectively restore lost structural volume, particularly in the midface and cheek area, where superficial fat compartment loss is most pronounced. The specific placement and product depend on which areas have lost the most support, assessed individually rather than through a fixed pattern.
For patients still losing weight, treatment is generally approached conservatively, since further volume loss may still occur. Once weight has stabilised, a more complete assessment of remaining volume loss and skin laxity can guide a longer-term filler and biostimulation plan. Coordinating timing with your weight-loss treatment, and being upfront with your aesthetic clinician about where you are in that process, helps avoid over- or under-correcting.
Patients who have experienced significant or rapid weight loss, whether from GLP-1 medication, surgery, or other means, and who notice increased facial hollowing, sagging or an aged appearance relative to the rest of their body change, may benefit from an individual assessment. This is particularly relevant for patients whose weight loss has been faster than typical age-related change would produce.
Facial volume loss after significant weight loss is increasingly common, and addressing it well starts with understanding exactly which layers- superficial fat, deeper support, or skin quality- are contributing to what you’re seeing.
At VIDASKIN, facial volume restoration after weight loss is planned around your individual weight-loss timeline, facial anatomy, and skin condition, combining biostimulation and structural filler as appropriate rather than a one-size-fits-all approach.
To learn more or book a consultation, visit or contact us today.
Dr. Kay Low is a UK-trained medical doctor with over 7 years of clinical experience across the UK and Singapore, specialising in aesthetic medicine. A graduate of the University of Cambridge, she has worked across multiple medical and surgical disciplines in the UK and Singapore before completing postgraduate training in Family Medicine and advanced training in aesthetic medicine.
